GlassScriptPhysician profile
Earl W Mcallister
NPI 1871692939
$1,308.65
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $286 · 2020: $543 · 2021: $192 · 2022: $288.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $450.21 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $141.26 | 2019-2022 | |
| Concordia Pharmaceuticals INC. | $121.37 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $99.92 | 2021-2022 | |
| Tela Bio, INC. | $72.33 | 2022 | |
| Intuitive Surgical, INC. | $56.27 | 2022 | |
| Innocoll Pharmaceuticals Limited | $42.00 | 2021-2022 | |
| Smith+Nephew, INC. | $39.77 | 2019 | |
| Kci USA, INC. | $36.50 | 2020-2021 | |
| Mallinckrodt Hospital Products INC. | $33.20 | 2021 | |
| Portola Pharmaceuticals, LLC | $29.96 | 2019 | |
| Angiodynamics, INC. | $27.50 | 2020 | |
| Redhill Biopharma INC. | $26.64 | 2020 | |
| Integra Lifesciences Corporation | $24.14 | 2021 | |
| Heron Therapeutics, INC. | $22.51 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $21.72 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $17.64 | 2020 | |
| Tei Biosciences INC | $17.22 | 2019 | |
| Alfasigma USA, INC. | $14.92 | 2020 | |
| Bard Access Systems, INC. | $13.57 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Earl Mcallister listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.